retatrutide phase 2 nejm weight loss 48 weeks percent Achieves Large Decreases in Patients Without Diabetes: TRIUMPH-1 Retatrutide vs Survodutide: 24% vs

What the Numbers Show Average weight loss by timepoint: Week 12: 8.7% total body weight (19 pounds for 220-pound person) Week 24: 17.3% total body weight (38 pounds for 220-pound person) Week 36: 21.1% total body weight (46 pounds for 220-pound person) Week 48: 24.2% total body weight (53 pounds for 220-pound person) Data from Phase 2 clinical trial, 12mg dose cohort

GHK-Cu dosing protocols frequently run for extended periods weeks to months because the tissue regeneration, skin research, and anti-aging biomarker effects develop slowly

Conway and Lauwers, 1961

This supplement is designed for those who need higher doses of glutathione for detoxification and immune support

Retatrutide is part of a new class of medications known as multi-agonist peptides, designed to target multiple pathways involved in appetite regulation and metabolism